GB0212357D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0212357D0
GB0212357D0 GBGB0212357.8A GB0212357A GB0212357D0 GB 0212357 D0 GB0212357 D0 GB 0212357D0 GB 0212357 A GB0212357 A GB 0212357A GB 0212357 D0 GB0212357 D0 GB 0212357D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0212357.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0212357.8A priority Critical patent/GB0212357D0/en
Publication of GB0212357D0 publication Critical patent/GB0212357D0/en
Priority to PCT/EP2003/005597 priority patent/WO2003099798A1/en
Priority to AU2003240730A priority patent/AU2003240730A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
GBGB0212357.8A 2002-05-29 2002-05-29 Novel compounds Ceased GB0212357D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0212357.8A GB0212357D0 (en) 2002-05-29 2002-05-29 Novel compounds
PCT/EP2003/005597 WO2003099798A1 (en) 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist
AU2003240730A AU2003240730A1 (en) 2002-05-29 2003-05-26 Morpholinylmethylureas ccr-3 receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0212357.8A GB0212357D0 (en) 2002-05-29 2002-05-29 Novel compounds

Publications (1)

Publication Number Publication Date
GB0212357D0 true GB0212357D0 (en) 2002-07-10

Family

ID=9937626

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0212357.8A Ceased GB0212357D0 (en) 2002-05-29 2002-05-29 Novel compounds

Country Status (3)

Country Link
AU (1) AU2003240730A1 (en)
GB (1) GB0212357D0 (en)
WO (1) WO2003099798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970946B2 (en) 2004-09-08 2012-07-11 田辺三菱製薬株式会社 Morpholine compounds
ES2764840T3 (en) 2015-01-28 2020-06-04 Univ Bordeaux Use of plerixafor to treat and / or prevent acute exacerbations of chronic obstructive pulmonary disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69527786T2 (en) * 1994-05-18 2003-04-10 Nisshin Seifun Group Inc DIAMINOMETHYLIDEN DERIVATIVES
WO2000071518A2 (en) * 1999-05-25 2000-11-30 Sepracor, Inc. Heterocyclic analgesic compounds and their use
PL362984A1 (en) * 2000-09-29 2004-11-15 Glaxo Group Limited Compounds useful in the treatment of inflammatory diseases
CN1678594A (en) * 2000-09-29 2005-10-05 葛兰素集团有限公司 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
WO2003099798A8 (en) 2004-01-15
AU2003240730A1 (en) 2003-12-12
WO2003099798A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB0202216D0 (en) Novel compounds
GB0205256D0 (en) Novel compounds
GB0202679D0 (en) Novel compounds
GB0206723D0 (en) Novel compounds
GB0207436D0 (en) Novel compounds
GB0225384D0 (en) Novel compounds
GB0203299D0 (en) Novel compounds
GB0204252D0 (en) Novel compounds
GB0212357D0 (en) Novel compounds
GB0207439D0 (en) Novel compounds
GB0203363D0 (en) Novel compounds
GB0202636D0 (en) Novel compounds
GB0206196D0 (en) Novel compounds
GB0205649D0 (en) Novel compounds
GB0204758D0 (en) Novel compounds
GB0204305D0 (en) Novel compounds
GB0204255D0 (en) Novel compounds
GB0203902D0 (en) Novel compounds
GB0203901D0 (en) Novel compounds
GB0203680D0 (en) Novel compounds
GB0203677D0 (en) Novel compounds
GB0203673D0 (en) Novel compounds
GB0203437D0 (en) Novel compounds
GB0203369D0 (en) Novel compounds
GB0206198D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)